DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Overview Fund Activity
Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

168 hedge funds and large institutions have $2.51B invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 69 increasing their positions, 47 reducing their positions, and 13 closing their positions.

Holders
168
Holders Change
+20
Holders Change %
+13.51%
% of All Funds
3.45%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
33
Increased
69
Reduced
47
Closed
13
Calls
$23.9M
Puts
$23.4M
Net Calls
+$497K
Net Calls Change
-$6.37M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$212M
2
BlackRock
2
BlackRock
New York
$184M
3
State Street
3
State Street
Massachusetts
$103M
4
Invesco
4
Invesco
Georgia
$21.2M
5
HRCM
5
Hood River Capital Management
Florida
$15.4M

Top Sellers

1
NLVP
1
New Leaf Venture Partners
New York
$72.2M
2
PC
2
Polar Capital
United Kingdom
$8.96M
3
Citadel Advisors
3
Citadel Advisors
Florida
$232K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$0
5
FCM
5
Farallon Capital Management
California
$42.7M
Name Market Value Shares Shares
Change 		Shares
Change %
RG
1
Redmile Group
California
$297M 4,978,941 -137,322 -3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$212M 3,549,561 +1,034,589 +41%
BlackRock
3
BlackRock
New York
$184M 3,089,206 +962,105 +45%
Franklin Resources
4
Franklin Resources
California
$175M 3,531,488 +294,105 +9%
ACA
5
Avoro Capital Advisors
New York
$111M 1,860,000 -140,000 -7%
State Street
6
State Street
Massachusetts
$103M 1,720,638 +649,251 +61%
ACH
7
ArrowMark Colorado Holdings
Colorado
$93.7M 1,568,669 -115,925 -7%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$91.9M 1,538,700 +62,879 +4%
AllianceBernstein
9
AllianceBernstein
Tennessee
$80.8M 1,353,077 +90,580 +7%
NLVP
10
New Leaf Venture Partners
New York
$72.2M 1,209,571 -877,152 -42%
O
11
OrbiMed
New York
$67.2M 1,125,700 -31,900 -3%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$48.5M 811,400 -148,753 -15%
FCM
13
Farallon Capital Management
California
$42.7M 715,000 -285,000 -29%
Alkeon Capital Management
14
Alkeon Capital Management
New York
$40.1M 670,975 +100,000 +18%
AG
15
Artal Group
Luxembourg
$38.8M 650,000 -150,000 -19%
PAMU
16
Pictet Asset Management (UK)
United Kingdom
$37.1M 621,810 +182,782 +42%
TCM
17
TimesSquare Capital Management
New York
$33.5M 560,530 -14,400 -3%
Goldman Sachs
18
Goldman Sachs
New York
$33.2M 555,375 +82,778 +18%
Wells Fargo
19
Wells Fargo
California
$29.8M 498,236 +32,810 +7%
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$27.8M 464,702 -212,984 -31%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$26.9M 450,768 +114,990 +34%
SHI
22
SV Health Investors
Massachusetts
$26.9M 449,951 – –
Northern Trust
23
Northern Trust
Illinois
$26.8M 448,270 +171,828 +62%
DM
24
Deerfield Management
New York
$25.2M 421,679 -167,806 -28%
EP
25
Eversept Partners
New York
$25M 418,652 +4,571 +1%
1
2 3 4 5